August 25, 2017
Statins reduce atherosclerotic cardiovascular disease (ASCVD) risk. However, the utility of statin therapy in older adults — particularly in those age 75 years and older — remains controversial. The need for additional evidence to guide clinical practice is underscored by the fact that one-in-three older Americans report taking a statin. Given the paucity of prospective data, a post-hoc analysis of the ALLHAT-LLT (Antihypertensive and Lipid Lowering treatment to prevent Heart Attack Trial - Lipid Lowering Trial) was recently published. Does this new analysis really help inform the decision?
Guest Author: Leo Buckley, Pharm.D.
Music by Good Talk
January 8, 2016
With increased emphasis on disease
prevention, gestational diabetes (GDM) is worthy of more attention. The
incidence is on the rise not only in the United States (U.S.) but worldwide. Complications of GDM such as preeclampsia, cesarean delivery, neonatal
hypoglycemia, macrosomia, and birth trauma negatively impact maternal and fetal
health. Is a readily available,
non-prescription dietary supplement the answer? Recent investigations have examined
the use of myo-inositol for GDM
prevention, with positive results.
December 22, 2015
Several studies have evaluated the correlation
between low-dose aspirin and NSAID use and the development of colorectal
cancer. In 2007, the U.S. Preventive Services Task Force (USPSTF) recommended against the use aspirin for the
prevention of colorectal cancer in most adults. However, there is
mounting evidence that daily, long-term aspirin use may prevent colorectal
cancer in patients aged 50-69. Could something as simple as an
aspirin a day prevent colon CA?
July 28, 2015
How well do cardiovascular disease risk calculators really perform? Do they over or underestimate risk? Should we rely on them to make treatment decisions?
July 24, 2015
Stroke is responsible for 1 in 19 deaths in the United States and is the leading cause of long-term disability. Could something as simple and cheap as folic acid substantially reduce the risk of stroke? The China Stroke Primary Prevention Trial examined this important question.